ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DCTH vs JNJ // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Delcath Systems Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: DCTH 4 — JNJ 5
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DCTH VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DCTH JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 86.20% 67.90% +18.30 DCTH /gross-margins <GO>
Return on Invested Capital (ROIC) 0.80% 25.50% -24.70 JNJ /roic <GO>
EV/EBITDA & P/E Valuation — 18.5x — TIE /valuation <GO>
Free Cash Flow Yield 4.13% 2.97% +1.16 DCTH /fcf-yield <GO>
Operating Margin 0.80% 34.70% -33.90 JNJ /operating-margins <GO>
Net Profit Margin 3.20% 28.50% -25.30 JNJ /net-margins <GO>
Revenue Growth (YoY) 129.10% 6.00% +123.10 DCTH /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 20.33 5.59 +14.74 DCTH /balance-sheet <GO>
Piotroski F-Score Quality 8/9 8/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 37.3 62.1 -24.82 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 23.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $508.0M $662.49B -$661.98B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DCTH REV JNJ REV DCTH GROSS % JNJ GROSS % DCTH FCF JNJ FCF
FY 2025 $85.2M $94.19B 86.2% 67.9% $21.0M $19.70B
FY 2024 $37.2M $88.82B 83.4% 69.1% -$19.2M $19.84B
FY 2023 $2.1M $85.16B — — -$31.3M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DCTH // BETA —
JNJ // BETA 1.08